• Je něco špatně v tomto záznamu ?

Suramin exposure alters cellular metabolism and mitochondrial energy production in African trypanosomes

M. Zoltner, GD. Campagnaro, G. Taleva, A. Burrell, M. Cerone, KF. Leung, F. Achcar, D. Horn, S. Vaughan, C. Gadelha, A. Zíková, MP. Barrett, HP. de Koning, MC. Field,

. 2020 ; 295 (24) : 8331-8347. [pub] 20200430

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20028093

Grantová podpora
MR/N010558/1 Medical Research Council - United Kingdom
204697/Z/16/Z Wellcome Trust - United Kingdom
MR/P009018/1 Medical Research Council - United Kingdom
104111/Z/14/Z Wellcome Trust - United Kingdom

Introduced about a century ago, suramin remains a frontline drug for the management of early-stage East African trypanosomiasis (sleeping sickness). Cellular entry into the causative agent, the protozoan parasite Trypanosoma brucei, occurs through receptor-mediated endocytosis involving the parasite's invariant surface glycoprotein 75 (ISG75), followed by transport into the cytosol via a lysosomal transporter. The molecular basis of the trypanocidal activity of suramin remains unclear, but some evidence suggests broad, but specific, impacts on trypanosome metabolism (i.e. polypharmacology). Here we observed that suramin is rapidly accumulated in trypanosome cells proportionally to ISG75 abundance. Although we found little evidence that suramin disrupts glycolytic or glycosomal pathways, we noted increased mitochondrial ATP production, but a net decrease in cellular ATP levels. Metabolomics highlighted additional impacts on mitochondrial metabolism, including partial Krebs' cycle activation and significant accumulation of pyruvate, corroborated by increased expression of mitochondrial enzymes and transporters. Significantly, the vast majority of suramin-induced proteins were normally more abundant in the insect forms compared with the blood stage of the parasite, including several proteins associated with differentiation. We conclude that suramin has multiple and complex effects on trypanosomes, but unexpectedly partially activates mitochondrial ATP-generating activity. We propose that despite apparent compensatory mechanisms in drug-challenged cells, the suramin-induced collapse of cellular ATP ultimately leads to trypanosome cell death.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20028093
003      
CZ-PrNML
005      
20210114152950.0
007      
ta
008      
210105s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1074/jbc.RA120.012355 $2 doi
035    __
$a (PubMed)32354742
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Zoltner, Martin $u School of Life Sciences, University of Dundee, Dundee, Scotland, United Kingdom.
245    10
$a Suramin exposure alters cellular metabolism and mitochondrial energy production in African trypanosomes / $c M. Zoltner, GD. Campagnaro, G. Taleva, A. Burrell, M. Cerone, KF. Leung, F. Achcar, D. Horn, S. Vaughan, C. Gadelha, A. Zíková, MP. Barrett, HP. de Koning, MC. Field,
520    9_
$a Introduced about a century ago, suramin remains a frontline drug for the management of early-stage East African trypanosomiasis (sleeping sickness). Cellular entry into the causative agent, the protozoan parasite Trypanosoma brucei, occurs through receptor-mediated endocytosis involving the parasite's invariant surface glycoprotein 75 (ISG75), followed by transport into the cytosol via a lysosomal transporter. The molecular basis of the trypanocidal activity of suramin remains unclear, but some evidence suggests broad, but specific, impacts on trypanosome metabolism (i.e. polypharmacology). Here we observed that suramin is rapidly accumulated in trypanosome cells proportionally to ISG75 abundance. Although we found little evidence that suramin disrupts glycolytic or glycosomal pathways, we noted increased mitochondrial ATP production, but a net decrease in cellular ATP levels. Metabolomics highlighted additional impacts on mitochondrial metabolism, including partial Krebs' cycle activation and significant accumulation of pyruvate, corroborated by increased expression of mitochondrial enzymes and transporters. Significantly, the vast majority of suramin-induced proteins were normally more abundant in the insect forms compared with the blood stage of the parasite, including several proteins associated with differentiation. We conclude that suramin has multiple and complex effects on trypanosomes, but unexpectedly partially activates mitochondrial ATP-generating activity. We propose that despite apparent compensatory mechanisms in drug-challenged cells, the suramin-induced collapse of cellular ATP ultimately leads to trypanosome cell death.
650    _2
$a adenosintrifosfát $x metabolismus $7 D000255
650    _2
$a energetický metabolismus $x účinky léků $7 D004734
650    _2
$a flagella $x účinky léků $x metabolismus $x ultrastruktura $7 D005407
650    _2
$a glykolýza $x účinky léků $7 D006019
650    _2
$a membránový potenciál mitochondrií $x účinky léků $7 D053078
650    _2
$a metabolom $x účinky léků $7 D055442
650    _2
$a mikrotělíska $x účinky léků $x metabolismus $x ultrastruktura $7 D008830
650    _2
$a mitochondrie $x účinky léků $x metabolismus $x ultrastruktura $7 D008928
650    _2
$a molekulární modely $7 D008958
650    _2
$a prolin $x metabolismus $7 D011392
650    _2
$a proteom $x metabolismus $7 D020543
650    _2
$a protonové ATPasy $x metabolismus $7 D006180
650    _2
$a protozoální proteiny $x metabolismus $7 D015800
650    _2
$a kyselina pyrohroznová $x metabolismus $7 D019289
650    _2
$a suramin $x farmakologie $7 D013498
650    _2
$a Trypanosoma brucei brucei $x metabolismus $7 D014346
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Campagnaro, Gustavo D $u Institute for Infection, Immunity, and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
700    1_
$a Taleva, Gergana $u Institute of Parasitology, Biology Centre, Czech Academy of Sciences, Institute of Parasitology, Faculty of Science, University of South Bohemia, České Budějovice, Czech Republic.
700    1_
$a Burrell, Alana $u Department of Biological and Medical Sciences, Oxford Brookes University, Oxford, United Kingdom.
700    1_
$a Cerone, Michela $u Institute for Infection, Immunity, and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
700    1_
$a Leung, Ka-Fai $u Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
700    1_
$a Achcar, Fiona $u Wellcome Centre for Integrative Parasitology and Glasgow Polyomics, University of Glasgow, Glasgow, United Kingdom.
700    1_
$a Horn, David $u School of Life Sciences, University of Dundee, Dundee, Scotland, United Kingdom.
700    1_
$a Vaughan, Sue $u Department of Biological and Medical Sciences, Oxford Brookes University, Oxford, United Kingdom.
700    1_
$a Gadelha, Catarina $u School of Life Sciences, University of Nottingham, Nottingham, United Kingdom.
700    1_
$a Zíková, Alena $u Institute of Parasitology, Biology Centre, Czech Academy of Sciences, Institute of Parasitology, Faculty of Science, University of South Bohemia, České Budějovice, Czech Republic.
700    1_
$a Barrett, Michael P $u Wellcome Centre for Integrative Parasitology and Glasgow Polyomics, University of Glasgow, Glasgow, United Kingdom.
700    1_
$a de Koning, Harry P $u Institute for Infection, Immunity, and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
700    1_
$a Field, Mark C $u School of Life Sciences, University of Dundee, Dundee, Scotland, United Kingdom mfield@mac.com. Institute of Parasitology, Biology Centre, Czech Academy of Sciences, Institute of Parasitology, Faculty of Science, University of South Bohemia, České Budějovice, Czech Republic.
773    0_
$w MED00002546 $t The Journal of biological chemistry $x 1083-351X $g Roč. 295, č. 24 (2020), s. 8331-8347
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32354742 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114152948 $b ABA008
999    __
$a ok $b bmc $g 1608428 $s 1119273
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 295 $c 24 $d 8331-8347 $e 20200430 $i 1083-351X $m The Journal of biological chemistry $n J Biol Chem $x MED00002546
GRA    __
$a MR/N010558/1 $p Medical Research Council $2 United Kingdom
GRA    __
$a 204697/Z/16/Z $p Wellcome Trust $2 United Kingdom
GRA    __
$a MR/P009018/1 $p Medical Research Council $2 United Kingdom
GRA    __
$a 104111/Z/14/Z $p Wellcome Trust $2 United Kingdom
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...